Chiuppesi F, Zaia J, Frankel P, Stan R, Drake J, Williams B, Acosta A, Francis K, Taplitz R, Dickter J, Dadwal S, Puing A, Nanayakkara D, Ash P, Cui Y, Contreras H, La Rosa C, Tiemann K, Park Y, Medina J, Iniguez A, Zhou Q, Karpinski V, Johnson D, Faircloth K, Kaltcheva T, Nguyen J, Kha M, Nguyen V, Francisco S, Grifoni A, Wong A, Sette A, Wussow F, Diamond D. Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial. The Lancet Microbe 2022, 3: e252-e264. PMID: 35287430, PMCID: PMC8906816, DOI: 10.1016/s2666-5247(22)00027-1.Peer-Reviewed Original Research